A Randomized, Open-Label, Single-Dose, Crossover Study of the Comparative Bioavailability of EPA and DHA in a Novel Liquid Crystalline Nanoparticle-Based Formulation of ω-3 Acid Ethyl Ester Versus Omacor® Soft Capsule among Healthy Adults
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms242417201 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Kwi-Man Kang und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Ajou University, Worldcup-ro 206, Yeongtong-gu, Suwon-si 16499, Republic of Korea. Hauptthemen laut MEDLINE: Eicosapentaenoic Acid, Fatty Acids, Omega-3. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of SMEs and Startups, Korea, Ministry of SMEs and Startups (MSS, Korea).
Abstract (Originalsprache)
Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are well known for their capacity to lower triglyceride levels, but the clinical effectiveness is hindered by limited bioavailability and patient adherence. To address this challenge, we introduce a novel liquid crystalline nanoparticle-based formulation, the innovative medicine and drug delivery (IMD)-Omega soft capsule (cap), designed to optimize the pharmacokinetics (PK) and safety of EPA and DHA. This randomized, open-label, crossover study engages a cohort of 24 healthy adult subjects, utilizing key PK parameters like Cmax, AUC, Tmax, t½, and Ke to conduct a comprehensive evaluation. The trial compares the performance of the IMD-Omega soft cap with the well-established Omacor® soft cap. The IMD-Omega soft cap exhibited an impressive 110% increase in bioavailability for EPA and a remarkable 134% surge for DHA in comparison to the Omacor® soft cap over a span of 72 h. The key success can be attributed to the innovative liquid crystalline nanoparticle design, bolstering the dissolution and permeability of these essential fatty acids. Intriguingly, intra-participant variability for AUC0–72 h and Cmax were calculated at 45.04% and 34.26%, respectively. It is noteworthy that the parameters of Tmax for EPA (≈6.00 h) and DHA (≈5.00 h), t½ for both EPA and DHA ≈ 30–40 h, and Kel around 0.18–0.22 h−1 for EPA and ≈0.008–0.02 h−1 for DHA, displayed comparability between the IMD-Omega and Omacor® formulations. Encouragingly, the IMD-Omega soft cap showed excellent tolerability. The promise of optimized patient compliance and reduced dosages adds further weight to its potential significance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Ajou University, Worldcup-ro 206, Yeongtong-gu, Suwon-si 16499, Republic of Korea.
- Research Center, IMDpharm Inc., 17, Daehak 4-ro, Yeongtong-gu, Suwon-si 16226, Republic of Korea.
- Bumin Hospital, 389, Gonghang-daero, Gangseo-gu, Seoul 07590, Republic of Korea.
ORCID-Profile: Anindita De, Young-Joon Park
Förderung
- Ministry of SMEs and Startups, Korea
- Ministry of SMEs and Startups (MSS, Korea)
Zitieren
APA
Kang, K. M., Jeon, S. W., De, A., Hong, T. S., & Park, Y. J. (2023). A Randomized, Open-Label, Single-Dose, Crossover Study of the Comparative Bioavailability of EPA and DHA in a Novel Liquid Crystalline Nanoparticle-Based Formulation of ω-3 Acid Ethyl Ester Versus Omacor® Soft Capsule among Healthy Adults. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242417201
Vancouver
Kang KM, Jeon SW, De A, Hong TS, Park YJ. A Randomized, Open-Label, Single-Dose, Crossover Study of the Comparative Bioavailability of EPA and DHA in a Novel Liquid Crystalline Nanoparticle-Based Formulation of ω-3 Acid Ethyl Ester Versus Omacor® Soft Capsule among Healthy Adults. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242417201
BibTeX
@article{Kang2023,
author = {Kang, Kwi-Man and Jeon, Sang-Won and De, Anindita and Hong, Tae-Sun and Park, Young-Joon},
title = {A Randomized, Open-Label, Single-Dose, Crossover Study of the Comparative Bioavailability of EPA and DHA in a Novel Liquid Crystalline Nanoparticle-Based Formulation of ω-3 Acid Ethyl Ester Versus Omacor® Soft Capsule among Healthy Adults},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms242417201}
}
EUVIMED